Adult Congenital Heart Disease · Milwaukee, WI
NPI
1184840175
Since 2007
Specialty
Adult Congenital Heart Disease
Code 207RA0002X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
9200 W Wisconsin Ave
Milwaukee, WI, 53226
Phone (414) 955-6777
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
1,733 services
Medicare patients, 2024
1,067
Average age 73
Drug cost, 2024
$1.8M
1,074 prescriptions
Company payments, 2025
$255
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott Cohen was code 93010 (electrocardiogram), 635 times for 499 patients. In total Scott Cohen billed 1,733 services in 29 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 635 | 499 | $5.91 | $3,753 |
| 93306 Echocardiography (TTE/TEE) | Facility | 309 | 306 | $45.30 | $14K |
| 93325 Echocardiography (TTE/TEE) | Facility | 116 | 107 | $2.26 | $262 |
| 93308 Echocardiography (TTE/TEE) | Facility | 91 | 81 | $18.06 | $1,644 |
| 93321 Echocardiography (TTE/TEE) | Facility | 82 | 73 | $5.11 | $419 |
| 99214 Office E&M - Established | Facility | 60 | 50 | $68.41 | $4,105 |
| 93306 Echocardiography (TTE/TEE) | Office | 54 | 54 | $142.57 | $7,699 |
| 99232 Hospital E&M - Subsequent | Facility | 51 | 20 | $58.43 | $2,980 |
| 93356 Echocardiography (TTE/TEE) | Facility | 42 | 38 | $8.05 | $338 |
| 93320 Echocardiography (TTE/TEE) | Facility | 39 | 39 | $12.43 | $485 |
| Q9956 Injection, octafluoropropane microspheres, per ml | Office | 36 | 12 | $31.60 | $1,138 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 32 | 32 | $11.16 | $357 |
| 93351 Echocardiography (TTE/TEE) | Facility | 23 | 23 | $58.70 | $1,350 |
| 93312 Echocardiography (TTE/TEE) | Facility | 22 | 22 | $73.75 | $1,623 |
| 93010 Electrocardiogram | Office | 16 | 16 | $4.95 | $79.22 |
By year: 2022 $45K for 1,663 services; 2023 $44K for 1,523 services; 2024 $48K for 1,733 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott Cohen prescribed most often to Medicare patients was Metoprolol Succinate, with 126 prescriptions and refills. In total Scott Cohen wrote 1,074 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 126 | 278 | 48 | $1,638 |
| Atorvastatin Calcium Generic | 103 | 260 | 38 | $1,168 |
| Losartan Potassium Generic | 67 | 183 | 27 | $517 |
| Entresto Sacubitril/Valsartan | 60 | 97 | 12 | $58K |
| Camzyos Mavacamten | 57 | 57 | Under 11 | $472K |
| Rosuvastatin Calcium Generic | 50 | 142 | 18 | $752 |
| Opsumit Macitentan | 40 | 40 | Under 11 | $496K |
| Furosemide Generic | 39 | 87 | 21 | $149 |
| Warfarin Sodium Generic | 36 | 102 | 11 | $199 |
| Spironolactone Generic | 35 | 95 | 15 | $197 |
| Lisinopril Generic | 31 | 85 | 13 | $290 |
| Farxiga Dapagliflozin Propanediol | 29 | 46 | Under 11 | $25K |
| Bumetanide Generic | 27 | 31 | Under 11 | $718 |
| Eliquis Apixaban | 26 | 38 | Under 11 | $22K |
| Tracleer Bosentan | 24 | 24 | Under 11 | $286K |
Brand drugs: 313 claims; generic drugs: 761 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott Cohen $255 ($255 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $255.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $255 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.